Antibiotic resistance is an ever growing threat to our armamentarium. 

Our primary focus for many years has been Infectious Diseases (ID). When it comes to IDs, we are all in this together - if I'm poorly treated and develop an antibiotic resistance strain, it not only affects me but all those around me - including you!

Teqqa is transforming how we treat infectious diseases. Our providers can view patient-specific antibiotic recommendations, collaborate as needed with our stewardship team, and opt to be notified when new information indicate a change in therapy may be warranted - all from the Teqqa app on their smartphone.
— Keith Hamilton, M.D., Associate Healthcare Epidemiologist and Director of Antimicrobial Stewardship at the Hospital of the University of Pennsylvania


Lack of education

Virtually every physician treats infections by prescribing antibiotics, but less than 1 in 100 has ID training. Thus, it's ripe for CDS.

Seasonality matters

All medicine moves fast, but in ID particularly, where new pathogens appear and resistance is always changing, it's even harder to keep up. 


ID is Local - so is treatment

The best treatment for AMI is conceptually the same everywhere in the country - and, by in large, world-wide. But for infectious diseases, the best treatment for where you live, where you've been, and who you've been in contact with all can have substantial impact on what is the best treatment for you.